Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: Analysis at ≥7 years of follow-up

BJU International

Volumn 100, Issue 2, 2007, Pages 362-367

  Cesaretti, Jamie A ^a   Kao, Johnny ^a   Stone, Nelson N ^a   Stock, Richard G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Erectile dysfunction; IIEF 5; Prostate brachytherapy; Prostate cancer

Indexed keywords

IODINE 125; LEAD; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; YOHIMBINE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION COEFFICIENT; ERECTILE DYSFUNCTION; EVALUATION AND FOLLOW UP; HUMAN; HUMAN TISSUE; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; SCORING SYSTEM; SEXUAL FUNCTION; SEXUAL HEALTH; STUDENT T TEST;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 34447125280     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07016.x     Document Type: Article

References (27)

1. Bill-Axelson A, Holmberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005 352 : 1977 84
2. Pollack A, Zagars GK, Starkschall G et al. Prostate cancer radiation dose-response. results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002 53 : 1097 105
3. Stock RG, Cesaretti JA, Stone NN. Disease-specific survival following the brachytherapy management of prostate cancer. Int J Radiat Oncol Biol Phys 2006 64 : 810 6
4. Stanford JL, Feng Z, Hamilton AS et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes study. JAMA 2000 283 : 354 60
5. Valicenti RK, Bissonette EA, Chen C, Theodorescu D. Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy. J Urol 2002 168 : 2499 504
6. Stock RG, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001 165 : 436 9
7. Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002 54 : 1063 8
8. Potosky AL, Davis WW, Hoffman RM et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004 96 : 1358 67
9. Talcott JA, Manola J, Clark JA et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 2003 21 : 3979 86
10. Potosky AL, Legler J, Albertsen PC et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000 92 : 1582 92
11. Kao J, Jani AB, Vijayakumar S. Sexual functioning after treatment for early stage prostate cancer. Sexuality Disability 2002 20 : 239 60
12. American Joint Committee on Cancer. Cancer Staging Manual. Philadelphia : Lippincott, 1992
13. Stock RG, Stone NN, Wesson MF, DeWyngaert JK. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 1995 32 : 219 25
14. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: Recommendations from the AAPM Radiation Therapy Committee Task Group no. 43. Medical Phys 1995 22 : 209 34
15. Williamson JF, Coursey BM, DeWerd LA et al. Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry: implications for dose specification and prescription. Med Phys 2000 27 : 634 42
16. Stock RG, Stone NN. Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer. Brachytherapy 2002 1 : 2 10
17. Anonymous. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997 37 : 1035 41
18. Stock RG, Stone NN, Iannuzzi CM. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1996 35 : 267 73
19. Stock RG, Stone NN, Iannuzzi C. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1996 35 : 267 72
20. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999 11 : 319 26
21. Cappelleri J, Siegel R, Glasser D, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile dysfunction and the Sexual Health Inventory for Men. Clin Therapeu 2001 23 : 1707 19
22. Raina R, Agarwal A, Ausmundson S, Mansour D, Zippe CD. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 2005 17 : 86 90
23. Montorsi F, Guazzoni G, Strambi LF et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997 158 : 1408 10
24. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1999 54 : 503 8
25. Walsh PC, Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br J Urol 1984 56 : 694 7
26. Begg CB, Riedel ER, Bach PB et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002 346 : 1138 44
27. Raina R, Lakin MM, Agarwal A et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 2004 63 : 960 6